REQUEST A DEMO
Total
USD $0.00
Search more companies

Imcopharma A.S. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Flour Milling | Sugar and Confectionery Product Manufacturing | Other Food Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Research and Development in Nanotechnology
Full name: Imcopharma A.S. Profile Updated: February 22, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Imcopharma a.s. operates as a pharmaceutical-industry solutions provider combining ingredient and product commercialization with a service platform supporting market access and lifecycle execution. Core activities include marketing and distribution of a wide range of pharmaceutical products and inputs sourced from GMP-certified producers, with a portfolio spanning APIs and nutra actives, excipients and nutraceutical ingredients, and related solutions for formulation development and manufacturing continuity. The service scope covers sampling programs, regulatory affairs and market-entry support, distribution warehousing and customs clearance, and project-oriented support including technology transfer, licensing (in-licensing and out-licensing strategy support) and structured project financing. The company also provides R&D support, including access to a fully equipped R&D laboratory to translate development outputs into practical implementation, and supports outsourcing models through CMO and CDMO solution facilitation. Geographic positioning is global with a stated specialization in Central and Eastern Europe and the CIS region, supported by an established network of subsidiaries in the CIS markets and cooperation with exclusive partners worldwide. Key assets include the commercial and technical platform integrating regulatory, logistics and development capabilities, supplier partnership network across pharmaceutical and nutraceutical value chains, and the companys product and service catalogue and portfolio navigation infrastructure. Strategically, the company positions as an integrated partner enabling pharmaceutical producers to accelerate sourcing, development, compliance and market execution, emphasizing innovative projects, close cooperation with customers, and operational flexibility across regulated markets.

Headquarters
Budovatelska 1178/35
Bilovec; Moravskoslezsky; Postal Code: 74301

Contact Details: Purchase the Imcopharma A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Imcopharma A.S. report to view the information.
Registered Capital:
Purchase the Imcopharma A.S. report to view the information.
Financial Auditors:
Purchase the Imcopharma A.S. report to view the information.
Incorporation Date:
May 14, 2008
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Ymkofarma Tov (Ukraine)
Company Performance
Financial values in the chart are available after Imcopharma A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
4.53%
Total operating revenue
2.03%
Operating Profit/Loss (EBIT)
-34.77%
EBITDA
-36.21%
Net Profit/Loss for the Period
-26.46%
Total Assets
-7.16%
Total Equity
-9.87%
Operating Profit Margin (ROS)
-3.52%
Net Profit Margin
-2.31%
Return on Equity (ROE)
-6.89%
Debt/Equity
-5.39%
Quick Ratio
-0.01%
Cash Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?